| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2006009741A1 Kinase inhibitors |
| 01/26/2006 | WO2006009653A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | WO2006009054A1 Phenethylnicotinamide compound |
| 01/26/2006 | WO2006008644A1 Antidiabetic compounds |
| 01/26/2006 | WO2006008260A1 Dimeric piperidine derivatives |
| 01/26/2006 | WO2006008259A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 01/26/2006 | WO2006008193A1 4-pyridinylethylcarboxamide derivatives useful as fungicides |
| 01/26/2006 | WO2006007843A1 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 01/26/2006 | WO2005116009B1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 01/26/2006 | WO2005097134A3 Quinazoline based protein kinase inhibitors |
| 01/26/2006 | WO2005094903A3 Contrast agents for magnetic resonance imaging |
| 01/26/2006 | WO2005086844A9 Magnetism to control friction checks for rods |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | WO2005077922A3 Process for the preparation of substituted triazole compounds |
| 01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 01/26/2006 | WO2005069981A3 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide |
| 01/26/2006 | WO2004096798A3 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists |
| 01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 01/26/2006 | US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060020000 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 01/26/2006 | US20060019997 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019995 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same |
| 01/26/2006 | US20060019994 I-sulphonlyl piperidine derivatives |
| 01/26/2006 | US20060019990 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019975 Novel piperidyl derivatives of quinazoline and isoquinoline |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019962 Modulators of muscarinic receptors |
| 01/26/2006 | US20060019956 Compositions useful as inhibitors of rock and other protein kinases |
| 01/26/2006 | US20060019953 Pyridine inhibitors of ERK2 and uses thereof |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019906 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 01/26/2006 | US20060016025 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| 01/26/2006 | DE102004031850A1 Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituirte tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 01/26/2006 | CA2579724A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | CA2574464A1 Substituted quinolones |
| 01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
| 01/26/2006 | CA2572822A1 Dimeric piperidine derivatives |
| 01/26/2006 | CA2572821A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders |
| 01/26/2006 | CA2570999A1 Compounds, compositions and methods |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1619221A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit |
| 01/25/2006 | EP1619220A1 Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 01/25/2006 | EP1618103A2 Polymorphs of aripiprazole |
| 01/25/2006 | EP1618094A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 01/25/2006 | EP1618093A2 Indazole derivatives as jnk inhibitors |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1513826B1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |
| 01/25/2006 | EP1446224B1 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 01/25/2006 | EP1347965B1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors |
| 01/25/2006 | EP1097158B1 Ligands for metals and metal-catalyzed processes |
| 01/25/2006 | EP0978392B1 Optical recording media |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726209A 3-substituted-4-pyrimidone derivatives |
| 01/25/2006 | CN1726208A Complexes of E-2-methoxy-N-(3-{4- [3-methyl-4-(6-methyl- pyridin -3-yloxy)-phenylamino] -quinazolin-6-yl}-allyl)-acetamide, their method of production, and use |
| 01/25/2006 | CN1726207A Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/25/2006 | CN1726206A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1726196A Pyrazine-based tubulin inhibitors |
| 01/25/2006 | CN1726194A Novel compounds |
| 01/25/2006 | CN1726042A Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 01/25/2006 | CN1724541A 2-(N-ethyl carbazole-3' olefine)-8-hydroxy quinoline metal compound ard its making method |
| 01/25/2006 | CN1724519A Indole kind compound with insuline sensitizing activity and its preparation method and use |
| 01/25/2006 | CN1238352C Process for producing pylidine compound |
| 01/25/2006 | CN1238343C Pyrimidine derivatives and herbicides containing the same |
| 01/25/2006 | CN1237969C Remedial agent for chronic articular rheumatism |
| 01/24/2006 | US6989449 Containing nitroxide or hydroxylamine moieties; use stabilizing pulp or paper against yellowing and discoloration due to light |
| 01/24/2006 | US6989448 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
| 01/24/2006 | US6989447 Compounds |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989394 Tetrahydropyridines |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/24/2006 | US6989382 Enzyme inhibitors; pyridin-2-yl-amino-ethyl-amino-phenyl derivatives; diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, obesity, cardiovascular disease, hypertension, polycystic ovary syndrome, ischemia, brain injury |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/24/2006 | US6989139 Matrix metalloproteinase inhibitors |
| 01/24/2006 | CA2433366C Amlodipine free base |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2238864C Method for the synthesis of a benzimidazole compound |